Ketamine
- Generic Name
- Ketamine
- Brand Names
- Ketalar
- Drug Type
- Small Molecule
- Chemical Formula
- C13H16ClNO
- CAS Number
- 6740-88-1
- Unique Ingredient Identifier
- 690G0D6V8H
- Background
Ketamine is an NMDA receptor antagonist with a potent anesthetic effect. It was developed in 1963 as a replacement for phencyclidine (PCP) by Calvin Stevens at Parke Davis Laboratories. It started being used for veterinary purposes in Belgium and in 1964 was proven that compared to PCP, it produced minor hallucinogenic effects and shorter psychotomimetic eff...
- Indication
Ketamine is indicated as an anesthetic agent for recommended diagnostic and surgical procedures. If skeletal muscle relaxation is needed, it should be combined with a muscle relaxant. If the surgical procedure involves visceral pain, it should be supplemented with an agent that obtunds visceral pain. Ketamine can be used for induction of anesthesia prior oth...
- Associated Conditions
- -
- Associated Therapies
- General Anesthesia, Induction and Maintenance of General Anesthesia
Ketamine for OUD and Suicidal Ideation in the ED
- Conditions
- Interventions
- First Posted Date
- 2023-11-01
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT06111339
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.
- Conditions
- Interventions
- First Posted Date
- 2023-11-01
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- National University of Malaysia
- Target Recruit Count
- 90
- Registration Number
- NCT06111872
- Locations
- 🇲🇾
Hospital Canselor Tuanku Muhriz UKM, Cheras, Kuala Lumpur, Malaysia
Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department
- First Posted Date
- 2023-10-17
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Lindsay Maguire, MD
- Target Recruit Count
- 50
- Registration Number
- NCT06085937
- Locations
- 🇺🇸
University of Kansas Strawberry Hill Campus, Kansas City, Kansas, United States
🇺🇸University of Kansas Medical Center Emergency Department, Kansas City, Kansas, United States
Prevention of Shivering Associated With Spinal Anesthesia
- Conditions
- Interventions
- First Posted Date
- 2023-10-13
- Last Posted Date
- 2023-10-13
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 90
- Registration Number
- NCT06082076
Dexmedetomidine Versus Ketamine Versus Magnesium Sulfate for the Prevention of Emergence Agitation Following Sevoflurane Induced Anesthesia in Cardiac Catheterization in Pediatrics
- Conditions
- Interventions
- First Posted Date
- 2023-10-11
- Last Posted Date
- 2023-10-11
- Lead Sponsor
- Cairo University
- Target Recruit Count
- 100
- Registration Number
- NCT06077539
- Locations
- 🇪🇬
Amany Hassan Saleh, Giza, Egypt
Ketamine-assisted Therapy for Advanced GI Cancer
- First Posted Date
- 2023-10-11
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Brian Anderson, MD
- Target Recruit Count
- 12
- Registration Number
- NCT06077487
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
RIVER At Home Ketamine Protocols
- Conditions
- Interventions
- First Posted Date
- 2023-10-06
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- RIVER Foundation
- Target Recruit Count
- 50000
- Registration Number
- NCT06070766
- Locations
- 🇺🇸
RIVER Telehealth, Helena, Montana, United States
🇺🇸RIVER Foundation, Bigfork, Montana, United States
Ketamine for MS Fatigue
- First Posted Date
- 2023-10-03
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- Alta Bates Summit Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT06064162
- Locations
- 🇺🇸
Alta Bates Summit Medical Center, Berkeley, California, United States
Impact of Ketamine on Depressive Symptoms in Patients Undergoing Lumbo-peritoneal Shunt Insertion
- First Posted Date
- 2023-09-29
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Benha University
- Target Recruit Count
- 60
- Registration Number
- NCT06060210
- Locations
- 🇪🇬
Banha faculity of medicine, Banha, Elqalyoubea, Egypt
The Perinatal Synergistic Multi-component Intervention to alLeviate dEpressive Symptoms. A Case Series
- Conditions
- Interventions
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2024-06-24
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 25
- Registration Number
- NCT06048263
- Locations
- 🇺🇸
Barnes-Jewish Hospital, Saint Louis, Missouri, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.